These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 38799468)

  • 1. Low-dose
    Peralta Alvarez MP; Jones H; Redondo Azema H; Davis C; White AD; Sarfas C; Dennis M; Li S; Wright D; Puentes E; Kimuda S; Belij-Rammerstorfer S; Aguilo N; Martin C; Sharpe S; McShane H; Tanner R
    Front Immunol; 2024; 15():1387454. PubMed ID: 38799468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial.
    Tameris M; Mearns H; Penn-Nicholson A; Gregg Y; Bilek N; Mabwe S; Geldenhuys H; Shenje J; Luabeya AKK; Murillo I; Doce J; Aguilo N; Marinova D; Puentes E; Rodríguez E; Gonzalo-Asensio J; Fritzell B; Thole J; Martin C; Scriba TJ; Hatherill M;
    Lancet Respir Med; 2019 Sep; 7(9):757-770. PubMed ID: 31416768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques.
    White AD; Sibley L; Sarfas C; Morrison AL; Bewley K; Churchward C; Fotheringham S; Gkolfinos K; Gooch K; Handley A; Humphries HE; Hunter L; Kennard C; Longet S; Mabbutt A; Moffatt M; Rayner E; Tipton T; Watson R; Hall Y; Bodman-Smith M; Gleeson F; Dennis M; Salguero FJ; Carroll M; McShane H; Cookson W; Hopkin J; Sharpe S
    Front Immunol; 2021; 12():801799. PubMed ID: 35222355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stronger induction of trained immunity by mucosal BCG or MTBVAC vaccination compared to standard intradermal vaccination.
    Vierboom MPM; Dijkman K; Sombroek CC; Hofman SO; Boot C; Vervenne RAW; Haanstra KG; van der Sande M; van Emst L; Domínguez-Andrés J; Moorlag SJCFM; Kocken CHM; Thole J; Rodríguez E; Puentes E; Martens JHA; van Crevel R; Netea MG; Aguilo N; Martin C; Verreck FAW
    Cell Rep Med; 2021 Jan; 2(1):100185. PubMed ID: 33521699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternate aerosol and systemic immunisation with a recombinant viral vector for tuberculosis, MVA85A: A phase I randomised controlled trial.
    Manjaly Thomas ZR; Satti I; Marshall JL; Harris SA; Lopez Ramon R; Hamidi A; Minhinnick A; Riste M; Stockdale L; Lawrie AM; Vermaak S; Wilkie M; Bettinson H; McShane H
    PLoS Med; 2019 Apr; 16(4):e1002790. PubMed ID: 31039172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary MTBVAC vaccination induces immune signatures previously correlated with prevention of tuberculosis infection.
    Dijkman K; Aguilo N; Boot C; Hofman SO; Sombroek CC; Vervenne RAW; Kocken CHM; Marinova D; Thole J; Rodríguez E; Vierboom MPM; Haanstra KG; Puentes E; Martin C; Verreck FAW
    Cell Rep Med; 2021 Jan; 2(1):100187. PubMed ID: 33521701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revaccination of Guinea Pigs With the Live Attenuated Mycobacterium tuberculosis Vaccine MTBVAC Improves BCG's Protection Against Tuberculosis.
    Clark S; Lanni F; Marinova D; Rayner E; Martin C; Williams A
    J Infect Dis; 2017 Sep; 216(5):525-533. PubMed ID: 28329234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCG vaccination improves DTaP immune responses in mice and is associated with lower pertussis incidence in ecological epidemiological studies.
    Broset E; Pardo-Seco J; Kanno AI; Aguilo N; Dacosta AI; Rivero-Calle I; Gonzalo-Asensio J; Locht C; Leite LCC; Martin C; Martinón-Torres F
    EBioMedicine; 2021 Mar; 65():103254. PubMed ID: 33711798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aerosol delivery, but not intramuscular injection, of adenovirus-vectored tuberculosis vaccine induces respiratory-mucosal immunity in humans.
    Jeyanathan M; Fritz DK; Afkhami S; Aguirre E; Howie KJ; Zganiacz A; Dvorkin-Gheva A; Thompson MR; Silver RF; Cusack RP; Lichty BD; O'Byrne PM; Kolb M; Medina MFC; Dolovich MB; Satia I; Gauvreau GM; Xing Z; Smaill F
    JCI Insight; 2022 Feb; 7(3):. PubMed ID: 34990408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Future Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit Vaccine.
    Gupta N; Garg S; Vedi S; Kunimoto DY; Kumar R; Agrawal B
    Front Immunol; 2018; 9():2371. PubMed ID: 30386336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robust IgM responses following intravenous vaccination with Bacille Calmette-Guérin associate with prevention of Mycobacterium tuberculosis infection in macaques.
    Irvine EB; O'Neil A; Darrah PA; Shin S; Choudhary A; Li W; Honnen W; Mehra S; Kaushal D; Gideon HP; Flynn JL; Roederer M; Seder RA; Pinter A; Fortune S; Alter G
    Nat Immunol; 2021 Dec; 22(12):1515-1523. PubMed ID: 34811542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of Functional Specific Antibodies, IgG-Secreting Plasmablasts and Memory B Cells Following BCG Vaccination.
    Bitencourt J; Peralta-Álvarez MP; Wilkie M; Jacobs A; Wright D; Salman Almujri S; Li S; Harris SA; Smith SG; Elias SC; White AD; Satti I; Sharpe SS; O'Shea MK; McShane H; Tanner R
    Front Immunol; 2021; 12():798207. PubMed ID: 35069580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: Protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations.
    Sharpe S; White A; Sarfas C; Sibley L; Gleeson F; McIntyre A; Basaraba R; Clark S; Hall G; Rayner E; Williams A; Marsh PD; Dennis M
    Tuberculosis (Edinb); 2016 Dec; 101():174-190. PubMed ID: 27865390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revaccination of cattle with bacille Calmette-Guérin two years after first vaccination when immunity has waned, boosted protection against challenge with Mycobacterium bovis.
    Parlane NA; Shu D; Subharat S; Wedlock DN; Rehm BH; de Lisle GW; Buddle BM
    PLoS One; 2014; 9(9):e106519. PubMed ID: 25180583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycobacterium tuberculosis infection is associated with increased B cell responses to unrelated pathogens.
    Kimuda SG; Andia-Biraro I; Sebina I; Egesa M; Nalwoga A; Smith SG; Bagaya BS; Levin J; Elliott AM; Raynes JG; Cose S
    Sci Rep; 2020 Aug; 10(1):14324. PubMed ID: 32868810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AdHu5Ag85A Respiratory Mucosal Boost Immunization Enhances Protection against Pulmonary Tuberculosis in BCG-Primed Non-Human Primates.
    Jeyanathan M; Shao Z; Yu X; Harkness R; Jiang R; Li J; Xing Z; Zhu T
    PLoS One; 2015; 10(8):e0135009. PubMed ID: 26252520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
    Deng YH; He HY; Zhang FJ
    Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccination.
    Lin MY; Geluk A; Smith SG; Stewart AL; Friggen AH; Franken KL; Verduyn MJ; van Meijgaarden KE; Voskuil MI; Dockrell HM; Huygen K; Ottenhoff TH; Klein MR
    Infect Immun; 2007 Jul; 75(7):3523-30. PubMed ID: 17502400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacille Calmette Guérin (BCG) and new TB vaccines: Specific, cross-mycobacterial and off-target effects.
    Fritschi N; Curtis N; Ritz N
    Paediatr Respir Rev; 2020 Nov; 36():57-64. PubMed ID: 32958428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.